PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AI can fake peer reviews and escape detection, study finds

2025-07-30
(Press-News.org)

Large language models (LLMs) like ChatGPT can be used to write convincing but biased peer reviews that are nearly impossible to distinguish from human writing, a new study reveals. This poses a serious threat to the integrity of scientific publishing, where peer review is the critical process for vetting research quality and accuracy.

In a study evaluating the risks of AI in academic publishing, a team of researchers from China tasked the AI model Claude with reviewing 20 real cancer research manuscripts. To closely simulate the real-world peer review process, they used the initial manuscripts submitted for review—sourced from the journal eLife's transparent peer review model—rather than the final, published versions of the articles. The AI was instructed to perform several tasks a human reviewer might: write a standard review, recommend a paper for rejection, and even request that authors cite specific articles—some of which were completely unrelated to the research topic.

The results were alarming. The researchers found that popular AI detection tools were largely ineffective, with one detector flagging over 80% of the AI-generated reviews as "human-written." While the AI's standard reviews often lacked the depth of an expert, it excelled at generating persuasive rejection comments and fabricating plausible-sounding reasons to cite irrelevant studies.

"We were surprised by how easily the LLM could generate convincing rejection comments and seemingly reasonable requests to cite unrelated papers," explains Peng Luo, one of the study's corresponding authors from the Department of Oncology at Zhujiang Hospital, Southern Medical University. "This creates a serious risk. Malicious reviewers could use this technology to unfairly reject good research or to manipulate citation numbers for their own benefit. The system is built on trust, and this technology can break that trust."

However, the researchers also found a potential upside. The same AI was effective at writing strong rebuttals to these unreasonable citation requests, offering a new tool for authors to defend their work against unfair criticism.

The authors urge the academic community to establish clear guidelines and new oversight mechanisms to ensure AI is used responsibly to support, not undermine, scientific integrity.

END



ELSE PRESS RELEASES FROM THIS DATE:

T cell senescence in the tumor microenvironment

2025-07-30
T cell senescence occurs in the TME, affecting cancer prognosis and immunotherapy efficacy. The TME induces T cell senescence through multiple pathways, including persistent stimulation by tumor-associated antigens, metabolic pathway alterations, activation of chronic inflammatory responses, proliferation of immunosuppressive cells, and T cell damage caused by tumor radiotherapy and chemotherapy. Senescent T cells exhibit characteristics such as genomic instability, protein imbalance, functional subgroup distribution and proportion imbalance, mitochondrial dysfunction with metabolic disorders, and epigenetic changes. Additionally, in the TME, crosstalk between senescent T cells and other immune ...

Simple solution to save lives globally: Low-cost ‘SimpleSilo’ offers hope for babies with gastroschisis

2025-07-30
In low-resource settings, babies born with gastroschisis — a congenital condition in which the developing intestines extend outside the body through a hole in the abdominal wall —face life-threatening challenges. While survival rates in high-income countries now exceed 90% thanks to advanced medical tools and neonatal care, infants in resource-constrained medical settings still face high mortality rates, partially because of a lack of access to the lifesaving equipment needed to treat the condition. A team of engineers ...

Curbing roadway fatalities hinges on shared responsibility and rethinking safety

2025-07-30
Drivers are not the only ones to blame for roadway fatalities. That's the crux of a review article in the New England Journal of Medicine written by a pair of Virginia Tech Transportation Institute (VTTI) researchers invited to share their insights on the strategies aimed at progressing toward a future with zero traffic deaths. Utilizing publicly available data, research publications, and their own expertise, Charlie Klauer and Zac Doerzaph evaluated the safety treatments and countermeasures that apply to what is known as the Safe System Approach, a framework that broadly embraces the concept that road users are not solely responsible ...

Beta-HPV can directly cause skin cancer in immunocompromised people

2025-07-30
EMBARGOED FOR RELEASE Wednesday, July 30, 2025 5 p.m. Eastern Time   Media Contact: NIH Office of Communications and Public Liaison (301) 496-5787   Beta-HPV can directly cause skin cancer in immunocompromised people NIH case study finds virus drives creation of cancer cells in context of defective T cells   Researchers at the National Institutes of Health (NIH) have shown for the first time that a type of human papillomavirus (HPV) commonly found on the skin can directly cause a form of skin cancer called cutaneous squamous cell ...

Efforts underway to end race-based assessments of lung function

2025-07-30
Multi-institutional team, including physicians and researchers who successfully proposed updates to national guidelines, share important next steps for reevaluating how occupational impairment is determined   Last July, a team of physicians and researchers successfully proposed modifications to the American Medical Association (AMA) Guides to the Evaluation of Permanent Impairment, advocating against the use of race in lung function testing. In a new publication in The New England Journal of Medicine, the team describes the history of how race and pulmonary function testing have been used to quantify lung function impairment, which often determines ...

CAR-T cell therapy linked to increased risk of secondary primary malignancies globally

2025-07-30
Each year, thousands of patients worldwide receive CAR-T cell therapy for blood cancers, achieving remarkable success in treating previously incurable conditions. However, concerns about secondary primary malignancies (SPMs) following this revolutionary treatment have prompted global regulatory attention. In a study published in eClinicalMedicine, a group of researchers from China examined the largest dataset to date analyzing secondary cancer risks after CAR-T therapy. "CAR-T therapy has transformed the treatment landscape for refractory blood cancers, ...

THER: integrative web tool for tumor hypoxia exploration and research

2025-07-30
Tumor hypoxia refers to the gradual decrease in ATP production when oxygen levels drop below a critical threshold, contributing to malignant tumor development. Studies show hypoxia-induced changes play an indispensable role in tumor progression, enabling tumors to become invasive or metastatic. However, hypoxia's effects vary across tumor types, and these mechanistic differences remain unclear. To address this, we developed THER (https://smuonco.shinyapps.io/THER/), an online tool that allows analysis of hypoxia-associated transcriptomic data without requiring programming skills. THER contains 63 preprocessed datasets from ...

How sources of dietary fat influence cancer growth in obesity

2025-07-30
July 30, 2025, NEW YORK – Obesity elevates the risk for at least 13 major cancers, including those of the breast, colon and liver. It also impairs immune responses that target tumors and are stimulated by cancer immunotherapies. But it has long been unclear whether these effects stem from the sheer adiposity—or mass of fat—in people living with obesity or from the specific dietary fats they consume. Now, a decade-long study led by Ludwig Princeton’s Lydia Lynch and reported in the current issue of Nature ...

Women less likely than men to receive MS drugs

2025-07-30
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, JULY 30, 2025 MINNEAPOLIS — Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women’s childbearing years, even when those drugs have been shown to be safe for use during pregnancy or to have a prolonged effect against the disease even when stopped before conception, according to a study published on July 30, 2025, in Neurology®, the medical journal of the American Academy of Neurology. “We found that women were less likely to be treated with a disease-modifying ...

AI language models sharpen chest CT diagnoses, speeding surgical decisions

2025-07-30
Interpreting the fine print of a chest CT report can make or break a patient’s surgical plan, yet radiologists worldwide face ballooning workloads and widening expertise gaps. A new study from Zhujiang Hospital of Southern Medical University analyzed 13,489 real-world chest CT reports and found that state-of-the-art LLMs can shoulder much of that burden—when asked the right way. ''We discovered that modern language models can act as a dependable second set of eyes for radiologists,'' said Dr. Peng Luo, lead author and physician at Zhujiang Hospital. ''With carefully worded multiple-choice ...

LAST 30 PRESS RELEASES:

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

[Press-News.org] AI can fake peer reviews and escape detection, study finds